Enabling Industry Applications in Clinical Trials
The healthcare and life sciences industry generates more information than any other industry in the world, making up 30% of the world’s data volume.
IQVIA’s Collection of Models, AI Agents and Reference Workflows
Announced today at the J.P. Morgan Conference in San Francisco, IQVIA’s collection of models, AI agents and reference workflows will be developed with the NVIDIA AI Foundry platform for building custom models, allowing IQVIA’s thousands of pharmaceutical, biotech and medical device customers to benefit from NVIDIA’s agentic AI capabilities and IQVIA’s technologies, life sciences information and expertise.
Enabling Industry Applications in Clinical Trials
The healthcare and life sciences industry generates more information than any other industry in the world, making up 30% of the world’s data volume.
IQVIA’s AI Applications
AI applications trained on the organization’s vast healthcare-specific information and guided by its deep domain expertise will help the industry boost the efficiency of clinical trials and optimize planning for the launch of therapies and medical devices — ultimately improving patient outcomes.
NVIDIA AI Foundry Streamlines Custom Model Development
To streamline the development of these AI agents, IQVIA is using tools within NVIDIA AI Foundry and the NVIDIA AI Enterprise software platform, including NVIDIA NIM microservices, especially the Llama Nemotron and Cosmos Nemotron model families; NVIDIA AI Blueprint reference workflows; the NVIDIA NeMo platform for developing custom generative AI; and dedicated capacity on NVIDIA DGX Cloud.
Automating Complex Tasks
Additional AI agents could automate complex, time-consuming tasks, like document generation and patient recruitment, allowing healthcare professionals to focus on strategic decision-making and human interaction.
Conclusion
The partnership between IQVIA and NVIDIA aims to accelerate the innovation cycle of IQVIA Healthcare-grade AI, ensuring that its AI-powered capabilities are grounded in privacy, regulatory compliance and patient safety.
Frequently Asked Questions
Q: What is the purpose of the partnership between IQVIA and NVIDIA?
A: The partnership aims to build custom foundation models and agentic AI workflows to accelerate research, clinical development, and access to new treatments.
Q: What are the benefits of this partnership?
A: The partnership will help the industry boost the efficiency of clinical trials and optimize planning for the launch of therapies and medical devices, ultimately improving patient outcomes.
Q: How will IQVIA and NVIDIA achieve this goal?
A: IQVIA will use its unparalleled information assets, analytics, and domain expertise, known as IQVIA Connected Intelligence, with the NVIDIA AI Foundry service to build language and multimodal foundational models that will power a collection of customized IQVIA AI agents.
